Skip to main content

Clue found to penis birth defect


Scientists have identified a gene which may play a role in a common defect affecting the genitalia of baby boys.

Hypospadias, which affects one in every 375 boys, is the result of incomplete development in the womb.

The latest research, in the journal Nature Genetics, found a gene which, when mutated, more than doubled the risk of the condition.

A UK researcher said it may help explain why hypospadias runs in families.
 
In boys who have the malformation, the opening of the urethral tube is not at the tip of the penis, but either further down the penis, at its base, or even further back, in the scrotum.

The normal solution is surgery at a young age, but even when corrected in this way, there can be long-term medical, psychological and sexual consequences.

The problem starts during the development of the sexual organs in the womb, and while there have been suggestions that exposure to environmental chemicals early in pregnancy may contribute, evidence to support this is not conclusive.

The only reliable clue has been the fact that the condition is more likely if a male relative has suffered it - pointing, at least in part, to a genetic origin.

Scientists had already found a gene playing a significant role in a more severe form of hypospadias, but the genetic mutations contributing to the more common, less severe version, have proved elusive.
Environmental factors 'trigger'

Researchers from King's College London, and Radboud University Njimegen Medical Centre in the Netherlands joined forces to carry out a large scale genome study.

This compared the genetic code of hundreds of boys, with and without the condition, to uncover genetic mutations which appeared more commonly in those with hypospadias.

They found that boys with a mutated version of the DGKK gene were 2.5 times more likely to be born with hypospadias.

Dr Jo Knight, from King's College London, said that this gene was found on the X-chromosome, which in boys can only be inherited from the mother.

She said: "We still don't know exactly how this causes the condition, so there is more research to be done to look at other genes and environmental factors that might trigger the malformation."

Professor Ieuan Hughes, a specialist in paediatrics at Cambridge University, said that it was likely that a number of genes acting together would be responsible for the condition.

He said: "People have been struggling for years to find out what the genes are that cause the common form of hypospadias, so this is an important study.

"However, it is certainly not clear how this gene might be creating the problem, and further work will be needed to confirm its involvement."

He said that although it had been suggested that environmental factors were contributing to hypospadias, he was "not quite convinced" that this was the case.

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

  Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...